NCT00359489

Brief Summary

Methods study to evaluate use of cardiac ultrasound to assess heart valve abnormality in people.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2007

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 2, 2006

Completed
8 months until next milestone

Study Start

First participant enrolled

April 1, 2007

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2007

Completed
Last Updated

September 17, 2007

Status Verified

September 1, 2007

First QC Date

July 31, 2006

Last Update Submit

September 13, 2007

Conditions

Heart Valve Diseases

Interventions

cardiac echosonographyDEVICE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>=18 years of age subjects with stable concomitant diseases with BMI \>=30 kg/m2

You may not qualify if:

  • Pregnant females
  • Those with unstable/new onset diseases
  • Those who are on agents known to be associated with cardiac valvular heart disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pfizer Investigational Site

New Haven, Connecticut, 06511-5473, United States

Location

Related Links

MeSH Terms

Conditions

Heart Valve Diseases

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Pfizer CT.gov Call Center

    Pfizer

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

July 31, 2006

First Posted

August 2, 2006

Study Start

April 1, 2007

Study Completion

July 1, 2007

Last Updated

September 17, 2007

Record last verified: 2007-09

Locations

US(1)